The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

The collaboration will see COUR and Roche’s Genentech leverage the biotech’s antigen-specific immune tolerance platform to ...

Cour Pharmaceuticals, a local biotech startup that’s raised north of $100 million from investors, has inked a new licensing ...

Chicago’s Cour Pharmaceuticals—recently honored as one of Fierce Biotech’s 2024 Fierce 15—is bringing its immunology mission ...

Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companieswith “Key, Near-Term, Potentially Stock-Moving ...

Target RWE, a leader in real-world evidence solutions in liver disease, presented important research on the use of ...